Eberhard Schleyer

P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

Thomas Illmer, Markus Schaich, Uwe Platzbecker et al. · Leukemia · 2004 · 306 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

Martin Bornhäuser, Barry E. Storer, John T. Slattery et al. · Blood · 2003 · 205 citations · Full text

Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588

Philipp le Coutre, Karl‐Anton Kreuzer, Stefan Pursche et al. · Cancer Chemotherapy and Pharmacology · 2003 · 158 citations

Physiologically-based Pharmacokinetic Modeling, Medicine, Cellular Uptake +6

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

G. Dresemann, Michael Weller, Mark Rosenthal et al. · Journal of Neuro-Oncology · 2009 · 153 citations

Neuro-oncology, Oncology, Medicine +9

Frequency and causes of refractoriness in multiply transfused patients

Tobias J. Legler, Imma Fischer, J. Dittmann et al. · Annals of Hematology · 1997 · 125 citations

Transfusion Medicine, Patient Safety, Blood Transfusion +1